Table of Content

Executive Summary
1 Market Overview
1.1 Pain Management Overview
1.2 Pain Management by Usage of Opioid Drugs
1.3 Pain Management by Usage of Non-Opioid Drugs and Devices
1.4 Evolution of Pain Relief Devices
1.5 Factors Propelling the Market Growth
1.6 Classification of Non-Opioid Pain Relief Devices Market
1.7 Potential Benefits and Risks of Non-Opioid Pain Relief Devices
1.8 Market Limitations and Assumptions

2 Market Dynamics
2.1 Overview
2.2 Market Drivers
2.2.1 Increase in Pain Incidences in Geriatric Population
2.2.2 Advent of Sedentary Lifestyle Leading to Increased Burden of Chronic Pain
2.2.3 Limited success Rate of Drugs Targeting Pain Disorders
2.2.4 High Number of Side Effects of the Opioid Drugs
2.3 Market Restraints
2.3.1 Insufficient Number of Long-Term Clinical Studies
2.3.2 Low Number of Pain Specialists Worldwide
2.3.3 Burden of Product Recalls
2.3.4 Limited Awareness Regarding Products Available
2.4 Market Trends
2.4.1 Shift of Demand Toward Wearable Technology
2.4.2 Miniaturization and Technological Advancement in the Pain Relief Technologies
2.4.3 Emergence of Minimally Invasive Therapies for Pain Relief
2.4.4 Non-Opioid Treatment for Pain Over Opioid Therapies

3 Competitive Landscape
3.1 Key Strategies and Developments
3.2 Key Strategies and Developments
3.2.1 Product Launches
3.2.2 Collaborations, Joint Ventures, and Partnerships
3.2.3 Awards and Recognitions
3.2.4 Mergers and Acquisitions
3.3 Market Share Analysis
3.3.1 Market Share Analysis (by Company)
3.4 Market Share Analysis (by Country)
3.5 Industry Attractiveness (Porter’s Five Forces Analysis)
3.5.1 Bargaining Power of Suppliers
3.5.1.1 Supplier to Firm Concentration Ratio
3.5.1.2 Presence of Brands
3.5.1.3 Degree of Product Differentiation
3.5.1.4 Threat of Forward Integration
3.5.2 Bargaining Power of Buyers
3.5.2.1 Buyer to Firm Concentration Ratio
3.5.2.2 Presence of Substitutes
3.5.2.3 Dependence on Distribution Channels
3.5.2.4 Buyer Information About Products
3.5.3 Threat of New Entrants
3.5.3.1 Regulatory Landscape
3.5.3.2 Brand Visibility
3.5.3.3 Product Differentiation
3.5.3.4 Capital Investments and Funding
3.5.4 Threat of Substitutes
3.5.4.1 Buyers’ Propensity toward Substitutes
3.5.4.2 Availability of Substitutes
3.5.4.3 Perceived Level of Product Differentiation
3.5.5 Intensity of Competitive Rivalry
3.5.5.1 Customer’s Loyalty Toward the Brand Image
3.5.5.2 Entry Barriers Through Innovations
3.5.5.3 Power of Competitive Strategy
3.6 Industry Insights
3.6.1 Regulatory Organizations/ Associations/ Consortiums

4 Global Non-Opioid Pain Relief Device Market (By Application)
4.1 Overview
4.2 Neuromuscular Pain
4.3 Musculoskeletal Pain
4.4 Injuries
4.5 Diabetic Neuropathy
4.6 Others

5 Global Non-Opioid Pain Relief Device Market (by Technology)
5.1 Overview
5.2 Electroanalgesia
5.2.1 Implantable Device
5.2.2 Non-Implantable Device
5.2.2.1 Traditional TENS
5.2.2.2 Wearable TENS
5.2.2.3 Others
5.3 Radiofrequency Ablation
5.4 Other Emerging Technologies

6 Global Non-Opioid Pain Relief Device Market (by End User)
6.1 Overview
6.2 Hospitals
6.3 Pain Management Centers
6.4 Homecare

7 Global Non-Opioid Pain Relief Device Market (by Region)
7.1 Overview
7.2 North America Non-Opioid Pain Relief Device Market
7.2.1 North America Non-Opioid Pain Relief Device Market, 2018-2029, $Million
7.2.2 North America Non-Opioid Pain Relief Device Market (by Application), 2018-2029, $Million
7.2.3 North America Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
7.2.4 North America Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
7.2.5 North America Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
7.2.6 North America Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
7.2.6.1 The U.S.
7.2.6.2 Canada
7.3 Europe Non-Opioid Pain Relief Device Market
7.3.1 Europe Non-Opioid Pain Relief Device Market, 2018-2029, $Million
7.3.2 Europe Non-Opioid Pain Relief Device Market (by Application), 2018-2029, $Million
7.3.3 Europe Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
7.3.4 Europe Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
7.3.4.1 The U.K.
7.3.4.2 Germany
7.3.4.3 Italy
7.3.4.4 France
7.3.4.5 Netherlands
7.3.4.6 Spain
7.3.4.7 Rest of Europe
7.4 Asia Pacific Non-Opioid Pain Relief Device Market
7.4.1 Asia-Pacific Non-Opioid Pain Relief Device Market, 2018-2029, $Million
7.4.2 Asia-Pacific Non-Opioid Pain Relief Device Market (by Application), 2018-2029, $Million
7.4.3 Asia-Pacific Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
7.4.4 Asia-Pacific Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
7.4.4.1 China
7.4.4.2 India
7.4.4.3 Japan
7.4.4.4 Australia
7.4.4.5 New Zealand
7.4.4.6 Rest-of-Asia-Pacific
7.5 Latin America Non-Opioid Pain Relief Device Market
7.5.1 Latin America Non-Opioid Pain Relief Device Market, 2018-2029, $Million
7.5.2 Latin America Non-Opioid Pain Relief Device Market (By Application), 2018-2029, $Million
7.5.3 Latin America Non-Opioid Pain Relief Device Market (By Technology), 2018-2029, $Million
7.5.4 Latin America Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
7.5.5 Latin America Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
7.5.5.1 Brazil
7.5.5.2 Mexico
7.5.5.3 Rest-of-Latin America
7.6 Middle East and Africa Non-Opioid Pain Relief Device Market, 2018-2029, $Million
7.6.1 Middle East and Africa Non-Opioid Pain Relief Device Market, 2018-2029, $Million
7.6.2 Middle East and Africa Non-Opioid Pain Relief Device Market (By Application), 2018-2029, $Million
7.6.3 Middle East and Africa Non-Opioid Pain Relief Device Market (By Technology), 2018-2029, $Million
7.6.4 Middle East and Africa Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
7.6.5 Middle East and Africa Non-Opioid Pain Relief Device Market (By Country), 2018-2029, $Million
7.6.5.1 Kingdom of Saudi Arabia
7.6.5.2 South Africa
7.6.5.3 Rest-of-Middle East and Africa

8 Company Profiles
8.1 Overview
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Role of Abbott Laboratories in the Global Non-Opioid Pain Relief Devices Market
8.2.3 Financials
8.2.4 SWOT Analysis
8.3 Bayer AG
8.3.1 Company Overview
8.3.2 Role of Bayer AG in the Global Non-opioid pain relief device Market
8.3.3 Financials
8.3.4 SWOT Analysis
8.4 Bioelectronics Corporation
8.4.1 Company Overview
8.4.2 Role of Bioelectronics Corporation in the Global Non-Opioid Pain Relief Devices Market
8.4.3 Financials
8.4.4 SWOT Analysis
8.5 Boston Scientific Corporation
8.5.1 Company Overview
8.5.2 Financials
8.5.3 SWOT Analysis
8.6 Medtronic plc
8.6.1 Company Overview
8.6.2 Role of Medtronic plc in the Non-Opioid Pain Relief Devices Market
8.6.3 Financials
8.6.4 Key Insights about Financial Health of the Company
8.6.5 SWOT Analysis
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Role of Koninklijke Philips N.V. in the Global non-opioid pain relief device Market
8.7.3 Financials
8.7.4 SWOT Analysis
8.8 NeuroMetrix Inc.
8.8.1 Company Overview
8.8.2 Role of NeuroMetrix, Inc. in the Non-Opioid Pain Relief Devices Market
8.8.3 Financials
8.8.4 SWOT Analysis
8.9 Nuvectra Corporation
8.9.1 Company Overview
8.9.2 Role of Nuvectra Corporation in the Global Non-Opioid Pain relief Device Market
8.9.3 Financials
8.9.4 SWOT Analysis
8.10 Omron Corporation
8.10.1 Company Overview
8.10.2 Role of Omron Corporation in the Global Non-Opioid Pain Relief Device Market
8.10.3 Financials
8.10.4 SWOT Analysis
8.11 Stryker Corporation
8.11.1 Company Overview
8.11.2 Role of Stryker Corporation in the Global Non-Opioid Pain Relief Device Market
8.11.3 Financials
8.11.4 SWOT Analysis
8.12 SPR Therapeutics, LLC
8.12.1 Company Overview
8.12.2 Role of SPR Therapeutics, LLC in the Global Non-Opioid Device Market
8.12.3 SWOT Analysis
8.13 Stimwave LLC
8.13.1 Company Overview
8.13.2 Role of Stimwave LLC in the Global Non-Opioid Device Market
8.13.3 SWOT Analysis
8.14 Thermotek Inc.
8.14.1 Company Overview
8.14.2 Role of Thermotek Inc. in the Global Non-Opioid Device Market
8.14.3 SWOT Analysis
8.15 Zynex Medical
8.15.1 Company Overview
8.15.2 Role of Zynex Medical in the Global Non-Opioid Device Market
8.15.3 Financials
8.15.4 SWOT Analysis

9 Research Scope and Methodology
9.1 Report Scope
9.2 Global Non-Opioid Pain Relief Device Market: Research Methodology
9.2.1 Primary Data Sources
9.2.2 Secondary Data Sources
9.2.3 Data Triangulation
9.3 Data and Prediction Modeling



List of Tables



Table 1: Impact of Market Drivers, 2018-2029
Table 2: Impact of Market Restraints, 2018-2029
Table 1.1: List of Non-Opioids Pain Relief Drugs*
Table 1.2: List of Non-Opioid Pain Relief Medical Devices*
Table 2.1: Global Mortality Census Post Opioid Usage Disorder (Year – 2015)
Table 2.2: Market Drivers: Impact Analysis
Table 2.3: Market Restraints: Impact Analysis
Table 3.1: Regulatory Bodies Related to Non-Opioid Pain Relief Devices (by Country)

List of Figures



Figure 1: Global Non-Opioid Pain Relief Device Market (by Application), 2018 and 2029
Figure 2: Global Non-Opioid Pain Relief Device Market (by Technology), 2018 and 2029
Figure 3: Global Non-Opioid Pain Relief Device Market (by End User), 2018 and 2029
Figure 4: Global Non-Opioid Pain Relief Device Market (by Region), 2019- 2029
Figure 5: Key Strategies Incorporated by the key Players in the Global Non-Opioid Pain Relief Device Market (January 2019 – April 2029)
Figure 6: Market Share Analysis for the Global Non-Opioid Pain Relief Device Market (by Company) (2018)
Figure 1.1: Global Non-Opioid Pain Relief Device Market, 2018-2029, $Million
Figure 2.1: Global Non-Opioid Pain Relief Device Market Dynamics
Figure 3.1: Share of Key Developments and Strategies, January 2016 -February 2019
Figure 3.2: Product Launches (by Company), January 2017-February 2019
Figure 3.3: Collaborations and Partnerships (by Company), January 2015-February 2019
Figure 3.4: Awards and Recognition (by Company), January 2015-February 2019
Figure 3.5: Mergers and Acquisitions Share (by Company), January 2015-February 2019
Figure 3.6: Market Share Analysis for the Global Non-Opioid Pain Relief Device Market, by Company (2018)
Figure 3.7: Market Share Analysis for the Global Non-Opioid Pain Relief Device Market (by Country) (2018 and 2029)
Figure 3.8: Industry Attractiveness (Porter’s Five Forces Analysis)
Figure 3.9: Analysis of Bargaining Power of Suppliers, 2018 and 2029
Figure 3.10 : Analysis of Bargaining Power of Buyers, 2018 and 2029
Figure 3.11 : Analysis of Threat of New Entrants, 2018 and 2029
Figure 3.12 : Analysis of Threat of Substitutes, 2018 and 2029
Figure 3.13 : Analysis of Intensity of Competitive Rivalry, 2018 and 2029
Figure 4.1: Global Non-Opioid Pain Relief Device Market (By Application), 2018-2029, $Million
Figure 4.2: Global Non-Opioid Pain Relief Device Market (Neuromuscular Pain), 2018-2029, $Million
Figure 4.3: Global Non-Opioid Pain Relief Device Market (Musculoskeletal Pain), 2018-2029, $Million
Figure 4.4: Global Non-Opioid Pain Relief Device Market (Injuries), 2018-2029, $Million
Figure 4.5: Global Non-Opioid Pain Relief Device Market (Diabetic Neuropathy), 2018-2029, $Million
Figure 4.6: Global Non-Opioid Pain Relief Device Market (Other Pain), 2018-2029, $Million
Figure 5.1: Global Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
Figure 5.2: Global Non-Opioid Pain Relief Device Market (Electroanalgesia), 2018-2029, $Million
Figure 5.3: Global Non-Opioid Pain Relief Device Market (By Electroanalgesia Technology), 2018 and 2029
Figure 5.4: Global Non-Opioid Pain Relief Device Market (Implantable Device), 2018-2029, $Million
Figure 5.5: Market Share Analysis of Key Players in the Implantable Pain Relief Device Market, $Million
Figure 5.6: Fragmentation of Non-Implantable Electroanalgesia Technologies- TENS, 2018 and 2029
Figure 5.7: Global Non-Opioid Pain Relief Device Market (Traditional TENS), 2018-2029, $Million
Figure 5.8: Market Share Analysis of Key Players in the Traditional TENS Device Market, $Million
Figure 5.9: Global Non-Opioid Pain Relief Device Market (Wearable TENS), 2018-2029, $Million
Figure 5.10: Market Share Analysis of Key Players in the Wearable TENS Device Market, $Million
Figure 5.11: Global Non-Opioid Pain Relief Device Market (Others), 2018-2029, $Million
Figure 5.12: Global Non-Opioid Pain Relief Device Market (Radiofrequency Ablation), 2018-2029, $Million
Figure 5.13: Market Share Analysis of Key Players in Radiofrequency Ablation Device Market, $Million
Figure 5.14: Global Non-Opioid Pain Relief Device Market (Other Emerging Technologies), 2018-2029, $Million
Figure 6.1: Global Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
Figure 6.2: Global Non-Opioid Pain Relief Devices Market (by Hospitals), 2018-2029, $Million
Figure 6.3: Global Non-Opioid Pain Relief Devices Market (by Pain Management Centres), 2018-2029, $Million
Figure 6.4: Global Non-Opioid Pain Relief Devices Market (by Homecare), 2018-2029, $Million
Figure 7.1: Global Non-Opioid Pain Relief Device Market Scenario (by Region), 2018 and 2029, $Million
Figure 7.2: North America Non-Opioid Pain Relief Device Market Scenario, 2018-2029, $Million
Figure 7.3: North America Non-Opioid Pain Relief Device Market Scenario (By Application), 2018 and 2029, $Million
Figure 7.4: North America Non-Opioid Pain Relief Device Market Scenario (by Application), 2018 and 2029, $Million
Figure 7.5: North America Non-Opioid Pain Relief Device Market Scenario (by End User), 2018 and 2029, $Million
Figure 7.6: North America Non-Opioid Pain Relief Device Market Scenario (by Country), 2018 and 2029, $Million
Figure 7.7: U.S. Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.8: Canada Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.9: Europe Non-Opioid Pain Relief Device Market Scenario, 2018 and 2029, $Million
Figure 7.10: Europe Non-Opioid Pain Relief Device Market, (By Application), 2018 and 2029, $Million
Figure 7.11: Europe Non-Opioid Pain Relief Device Market Scenario (By Technology), 2018 and 2029, $Million
Figure 7.12: Europe Non-Opioid Pain Relief Device Market Scenario (by Country), 2018 and 2029, $Million
Figure 7.13: The U.K. - Non-Opioid Pain Relief Device Market, 2018-2029, $Million
Figure 7.14: Germany- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.15: Italy-Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.16: France- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.17: Netherlands- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.18: Spain- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.19: Rest of Europe Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.20: Asia-Pacific Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.21: Asia-Pacific Non-Opioid Pain Relief Device Market Scenario (by Application), 2018 and 2029, $Million
Figure 7.22: Asia-Pacific Non-Opioid Pain Relief Device Market Scenario (by Technology), 2018 and 2029, $Million
Figure 7.23: Asia-Pacific Non-Opioid Pain Relief Device Market Scenario (by Country), 2018 and 2029, $Million
Figure 7.24: China Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.25: India Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.26: Japan Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.27: Australia Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.28: New Zealand Non-Opioid Pain Relief Device Market, 2018-2029, $Million
Figure 7.29: Rest-of-Asia-Pacific Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.30: Latin America Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.31: Latin America Non-Opioid Pain Relief Device Market Scenario (by Application), 2018 and 2029, $Million
Figure 7.32: Latin America Non-Opioid Pain Relief Device Market (by Technology), 2018 and 2029, $Million
Figure 7.33: Latin America Non-Opioid Pain Relief Device Market (by End User), 2018 and 2029, $Million
Figure 7.34: Latin America Non-Opioid Pain Relief Device Market (By Country), 2018 and 2029, $Million
Figure 7.35: Brazil Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.36: Mexico Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.37: Rest-of-Latin America Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.38: Middle East and Africa Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.39: Middle East and Africa Non-Opioid Pain Relief Device Market (By Application), 2018 and 2029, $Million
Figure 7.40: Middle East and Africa Non-Opioid Pain Relief Device Market Scenario (By Technology), 2018 and 2029, $Million
Figure 7.41: Middle East and Africa Non-Opioid Pain Relief Device Market (By End-user), 2018 and 2029, $Million
Figure 7.42: Middle East and Africa Non-Opioid Pain Relief Device Market (by Country), 2018 and 2029, $Million
Figure 7.43: Kingdom of Saudi Arabia Non-Opioid Pain Relief Device Market, 2018 and 2029, $Million
Figure 7.44: South Africa Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.45: South Africa Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 8.1: Total Number of Companies Profiled
Figure 8.2: Abbott Laboratories: Overall Product Portfolio for Global Non-opioid Pain Relief Device Market
Figure 8.3: Abbott Laboratories: Overall Financials, 2016-2018
Figure 8.4: Abbott Laboratories: Revenue (by Segment), 2016-2018
Figure 8.5: Abbott Laboratories: Revenue (by Region), 2016-2018
Figure 8.6: Abbott Laboratories: R&D Expenditure, 2016-2018
Figure 8.7: Abbott Laboratories: SWOT Analysis
Figure 8.8: Bayer AG - Product Portfolio for Global Non-Opioid Pain Relief Device Market
Figure 8.9: Bayer AG - Overall Financials, 2016-2018
Figure 8.10: Bayer AG - Revenue (by Segment), 2016-2018
Figure 8.11: Bayer AG - Revenue (by Region), 2016-2018
Figure 8.12: Bayer AG - R&D Expenditure, 2016-2018
Figure 8.13: SWOT Analysis: Bayer AG
Figure 8.14: BioElectronics Corporation: Overall Product Portfolio
Figure 8.15: Bioelectronics Corporation - Overall Financials, 2015-2017
Figure 8.16: Bioelectronics Corporation: R&D Expenditure, 2015-2017
Figure 8.17: SWOT Analysis: Bioelectronics Corporation
Figure 8.18: Boston Scientific Corporation: Overall Product Portfolio
Figure 8.19: Boston Scientific Corporation: Overall Financials, 2016-2018
Figure 8.20: Boston Scientific Corporation: Revenue (by Segment), 2016-2018
Figure 8.21: Boston Scientific Corporation: Revenue (by Region), 2016-2018
Figure 8.22: Boston Scientific Corporation: R&D Expenditure, 2016-2018
Figure 8.23: SWOT Analysis: Boston scientific Corporation
Figure 8.24: Medtronic Plc: Overall Product Portfolio
Figure 8.25: Medtronic Plc: Overall Financials, 2016-2018
Figure 8.26: Medtronic plc: Revenue (by Segment), 2016-2018
Figure 8.27: Medtronic plc: Revenue (by Region), 2016-2018
Figure 8.28: Medtronic Plc: R&D Expenditure, 2016-2018
Figure 8.29: Medtronic plc: SWOT Analysis
Figure 8.30: Koninklijke Philips N.V. - Product Portfolio for Global non-opioid pain relief device Market
Figure 8.31: Koninklijke Philips N.V. - Overall Financials, 2016-2018
Figure 8.32: Koninklijke Philips N.V. - Revenue (by Segment), 2016-2018
Figure 8.33: Koninklijke Philips N.V. - Revenue (by Region), 2016-2018
Figure 8.34: Koninklijke Philips N.V. - R&D Expenditure, 2016-2018
Figure 8.35: SWOT Analysis - Koninklijke Philips N.V.
Figure 8.36: NeuroMetrix, Inc.: Overall Product Portfolio
Figure 8.37: Neurometrix Inc. - Overall Financials, 2016-2018
Figure 8.38: Neurometrix Inc.: R&D Expenditure, 2016-2018
Figure 8.39: SWOT Analysis: Neurometrix, Inc.
Figure 8.40: Nuvectra Corporation: Overall Product Portfolio
Figure 8.41: Neurometrix Inc. - Overall Financials, 2016-2018
Figure 8.42: Nuvectra Corporation: Revenue by Segment, 2016-2018
Figure 8.43: Nuvectra Corporation: Revenue by Region, 2016-2018
Figure 8.44: Nuvectra Corporation R&D Expenditure, 2016-2018
Figure 8.45: SWOT Analysis – Nuvectra Corporation
Figure 8.46: Omron Corporation - Product Portfolio for Global non-opioid pain relief device Market
Figure 8.47: Omron Corporation - Overall Financials, 2015-2017
Figure 8.48: Omron Corporation: Revenue by Segment, 2015-2017
Figure 8.49: Omron Corporation: Revenue by Region, 2015-2017
Figure 8.50: Omron Corporation: R&D Expenditure, 2015-2017
Figure 8.51: SWOT Analysis – Omron Corporation
Figure 8.52: Stryker Corporation - Product Portfolio for global non-opioid pain relief device market Market
Figure 8.53: Stryker Corporation - Overall Financials, 2016-2018
Figure 8.54: Stryker Corporation: Revenue by Segment, 2016-2018
Figure 8.55: Stryker Corporation - Revenue (by Region), 2016-2018
Figure 8.56: Stryker Corporation R&D Expenditure, 2016-2018
Figure 8.57: SWOT Analysis – Stryker Corporation
Figure 8.58: SPR Therapeutics: Overall Product Portfolio
Figure 8.59: SWOT Analysis – SPR Therapeutics
Figure 8.60: Stimwave LLC: Overall Product Portfolio
Figure 8.61: SWOT Analysis – Stimwave LLC
Figure 8.62: Thermotek Inc.: Overall Product Portfolio
Figure 8.63: SWOT Analysis – Thermotek Inc.
Figure 8.64: Zynex Medical: Overall Product Portfolio
Figure 8.65: Zynex Medical - Overall Financials, 2016-2018
Figure 8.66: Zynex Medical R&D Expenditure, 2016-2018
Figure 8.67: SWOT Analysis : Zynex Medical
Figure: 9.1: Global Non-Opioid Pain Relief Device Market
Figure: 9.2: Global Non- Opioid Pain Relief DeviceMarket: Research Methodology
Figure: 9.3: Secondary Research
Figure: 9.4: Data Triangulation
Figure: 9.5: Bottom-Up Approach
Figure: 9.6: Top-Down Approach
Figure: 9.7: Considered Factors for Data Prediction and Modelling